In honor of the late John Holaday, Ph.D., a luminary in the fields of science, entrepreneurship, philanthropy, and community leadership, the ‘John Holaday’ BioHealth Leadership Award stands as a beacon recognizing those who embody his guiding principle — “do well by doing good.” Meet the 2023 finalists, nominated by YOU.
How Two Former IT Industry Professionals Found their Calling as Gene Therapy CEOs By Chris Frew | November 22, 2023 In most cases, the prerequisites for the CEO of a [….]
The Rockville-based company, an anticipated SPAC merger of American Gene Technologies HIV business and a 10x Capital Venture Acquisition Corp. III, will list on the New York Stock Exchange under the ticker symbol HIV. The company will have a valuation of $500 million. Funds will be used to advance clinical development of Addimmune’s cell therapy for HIV.
American Gene Technologies Spins Off Addimmune as a Separate Company With a Focus on Curing HIV By Alex KeownJune 9, 2023 Powered by promising Phase I results from its HIV [….]
